|
1
|
Alqudah MA, Agarwal S, Al-Keilani MS,
Sibenaller ZA, Ryken TC and Assem M: NOTCH3 is a prognostic factor
that promotes glioma cell proliferation, migration and invasion via
activation of CCND1 and EGFR. PLoS One. 8:e772992013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakada M, Nakada S, Demuth T, Tran NL,
Hoelzinger DB and Berens ME: Molecular targets of glioma invasion.
Cell Mol Life Sci. 64:458–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sciumè G, Santoni A and Bernardini G:
Chemokines and glioma: Invasion and more. J Neuroimmunol. 224:8–12.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Agudelo-Garcia PA, De Jesus JK, Williams
SP, Nowicki MO, Chiocca EA, Liyanarachchi S, Li PK, Lannutti JJ,
Johnson JK, Lawler SE, et al: Glioma cell migration on
three-dimensional nanofiber scaffolds is regulated by substrate
topography and abolished by inhibition of STAT3 signaling.
Neoplasia. 13:831–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Godlewski J, Bronisz A, Nowicki MO,
Chiocca EA and Lawler S: microRNA-451: A conditional switch
controlling glioma cell proliferation and migration. Cell Cycle.
9:2742–2748. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Small JV, Stradal T, Vignal E and Rottner
K: The lamellipodium: Where motility begins. Trends Cell Biol.
12:112–120. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamaguchi H and Condeelis J: Regulation of
the actin cytoskeleton in cancer cell migration and invasion.
Biochim Biophys Acta. 1773:642–652. 2007. View Article : Google Scholar
|
|
8
|
Wu C, Asokan SB, Berginski ME, Haynes EM,
Sharpless NE, Griffith JD, Gomez SM and Bear JE: Arp2/3 is critical
for lamellipodia and response to extracellular matrix cues but is
dispensable for chemotaxis. Cell. 148:973–987. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Suraneni P, Rubinstein B, Unruh JR, Durnin
M, Hanein D and Li R: The Arp2/3 complex is required for
lamellipodia extension and directional fibroblast cell migration. J
Cell Biol. 197:239–251. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goley ED and Welch MD: The ARP2/3 complex:
An actin nucleator comes of age. Nat Rev Mol Cell Biol. 7:713–726.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koestler SA, Steffen A, Nemethova M,
Winterhoff M, Luo N, Holleboom JM, Krupp J, Jacob S, Vinzenz M,
Schur F, et al: Arp2/3 complex is essential for actin network
treadmilling as well as for targeting of capping protein and
cofilin. Mol Biol Cell. 24:2861–2875. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iwaya K, Norio K and Mukai K: Coexpression
of Arp2 and WAVE2 predicts poor outcome in invasive breast
carcinoma. Mod Pathol. 20:339–343. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Z, Yang X, Chen C, Liu B, Ren B, Wang
L, Zhao K, Yu S and Ming H: Expression of the Arp2/3 complex in
human gliomas and its role in the migration and invasion of glioma
cells. Oncol Rep. 30:2127–2136. 2013.PubMed/NCBI
|
|
14
|
Croucher DR, Rickwood D, Tactacan CM,
Musgrove EA and Daly RJ: Cortactin modulates RhoA activation and
expression of Cip/Kip cyclin-dependent kinase inhibitors to promote
cell cycle progression in 11q13-amplified head and neck squamous
cell carcinoma cells. Mol Cell Biol. 30:5057–5070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Macgrath SM and Koleske AJ: Cortactin in
cell migration and cancer at a glance. J Cell Sci. 125:1621–1626.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weaver AM, Karginov AV, Kinley AW, Weed
SA, Li Y, Parsons JT and Cooper JA: Cortactin promotes and
stabilizes Arp2/3-induced actin filament network formation. Curr
Biol. 11:370–374. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weed SA, Karginov AV, Schafer DA, Weaver
AM, Kinley AW, Cooper JA and Parsons JT: Cortactin localization to
sites of actin assembly in lamellipodiarequires interactions with
F-actin and the Arp2/3 complex. J Cell Biol. 29–40. 2000.
View Article : Google Scholar
|
|
18
|
Bryce NS, Clark ES, Leysath JL, Currie JD,
Webb DJ and Weaver AM: Cortactin promotes cell motility by
enhancing lamellipodial persistence. Curr Biol. 15:1276–1285. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dedes KJ, Lopez-Garcia MA, Geyer FC,
Lambros MB, Savage K, Vatcheva R, Wilkerson P, Wetterskog D,
Lacroix-Triki M, Natrajan R, et al: Cortactin gene amplification
and expression in breast cancer: A chromogenic in situ
hybridisation and immunohistochemical study. Breast Cancer Res
Treat. 124:653–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Desmarais V, Yamaguchi H, Oser M, Soon L,
Mouneimne G, Sarmiento C, Eddy R and Condeelis J: N-WASP and
cortactin are involved in invadopodium-dependent chemotaxis to EGF
in breast tumor cells. Cell Motil Cytoskeleton. 66:303–316. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hofman P, Butori C, Havet K, Hofman V,
Selva E, Guevara N, Santini J and Van Obberghen-Schilling E:
Prognostic significance of cortactin levels in head and neck
squamous cell carcinoma: Comparison with epidermal growth factor
receptor status. Br J Cancer. 98:956–964. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamada S, Yanamoto S, Kawasaki G, Mizuno A
and Nemoto TK: Overexpression of cortactin increases invasion
potential in oral squamous cell carcinoma. Pathol Oncol Res.
16:523–531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Perrin BJ, Amann KJ and Huttenlocher A:
Proteolysis of cortactin by calpain regulates membrane protrusion
during cell migration. Mol Biol Cell. 17:239–250. 2006. View Article : Google Scholar :
|
|
24
|
Giese A, Bjerkvig R, Berens Me and
Westphal M: Cost of migration: Invasion of malignant gliomas and
implications for treatment. J Clin oncol. 21:1624–1636. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Westermark B: Glioblastoma - a moving
target. Ups J Med Sci. 117:251–256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weaver AM: Cortactin in tumor
invasiveness. Cancer Lett. 265:157–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tehrani S, Faccio R, Chandrasekar I, Ross
FP and Cooper JA: Cortactin has an essential and specific role in
osteoclast actin assembly. Mol Biol Cell. 17:2882–2895. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hou H, Chen W, Zhao L, Zuo Q, Zhang G,
Zhang X, Wang H, Gong H, Li X, Wang M, et al: Cortactin is
associated with tumour progression and poor prognosis in prostate
cancer and SIRT2 other than HADC6 may work as facilitator in situ.
J Clin Pathol. 65:1088–1096. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jovčevska I, Kočevar N and Komel R: Glioma
and glioblastoma - how much do we (not) know? Mol Clin oncol.
1:935–941. 2013.
|
|
30
|
Rao JS: Molecular mechanisms of glioma
invasiveness: The role of proteases. Nat Rev Cancer. 3:489–501.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pfaendtner J, Volkmann N, Hanein D,
Dalhaimer P, Pollard TD and Voth GA: Key structural features of the
actin filament Arp2/3 complex branch junction revealed by molecular
simulation. J Mol Biol. 416:148–161. 2012. View Article : Google Scholar :
|
|
32
|
Chang L, Su J, Jia X and Ren H: Treating
malignant glioma in Chinese patients: Update on temozolomide. Onco
Targets Ther. 7:235–244. 2014.PubMed/NCBI
|
|
33
|
Reardon DA, Fink KL, Mikkelsen T,
Cloughesy TF, O'Neill A, Plotkin S, Glantz M, Ravin P, Raizer JJ,
Rich KM, et al: Randomized phase II study of cilengitide, an
integrin-targeting arginine-glycine-aspartic acid peptide, in
recurrent glioblastoma multiforme. J Clin Oncol. 26:5610–5617.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Eisele G, Wick A, Eisele A-C, Clément PM,
Tonn J, Tabatabai G, Ochsenbein A, Schlegel U, Neyns B, Krex D, et
al: Cilengitide treatment of newly diagnosed glioblastoma patients
does not alter patterns of progression. J Neurooncol. 117:141–145.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cheng NC, van Zandwijk N and Reid G:
Cilengitide inhibits attachment and invasion of malignant pleural
mesothelioma cells through antagonism of integrins αvβ3 and αvβ5.
PLoS One. 9:e903742014. View Article : Google Scholar
|
|
36
|
Yu X, Zech T, McDonald L, Gonzalez EG, Li
A, Macpherson I, Schwarz JP, Spence H, Futó K, Timpson P, et al:
N-WASP coordinates the delivery and F-actin-mediated capture of
MT1-MMP at invasive pseudopods. J Cell Biol. 199:527–544. 2012.
View Article : Google Scholar : PubMed/NCBI
|
